Skip to content

MAES PHARMCONSULT

Active Private limited companyfounded 2005active for 21 yearsRue de Dalhem 5, 4600 ViséKBO/BCE: BE 0875.845.464

Lifetime

20 annual accounts with figures on one time axis
peak of €194,748 in 2014
€21,025▲ 12.8%
lowest -€2,948 in 2014
€3,689▼ 21.9%
peak of €160,970 in 2025
€160,970▲ 2.3%
€310,901▲ 36.5%
Board1 name since 2023
1 director
Documentsfilings and deeds
07-07-202624 days before the deadline
2025micro format
Gross margin from €18,642 to €21,025Registered office moved within Visé 14-03Debts from €227,774 to €310,901Investments €73,103Cash from €22,585 to €52,413

Key points

from the 2025 annual accounts

Equity

€160,970 ▲ 2.3%

MAES PHARMCONSULT has made a profit without a break since 2015.

Investments

€8,603 5.1 times depreciation
202120232025

Green is investment, beige is depreciation. Machinery stands 1092.0% higher than in 2024.

Payment terms

478 days to suppliers
Suppliers
278 to 478

MAES PHARMCONSULT pays its suppliers 200 days later than in 2024.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-12-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0875845464
Registered office moved within Visé The registered office moved from rue de Maastricht 5, 4600 Visé to rue de Dalhem n°5, 4600 Visé · General meeting of 04-02-2025 · Gazette deed
changes role from manager to director acts as permanent representative · Discharge granted to (manager) · General meeting of 20-12-2023 · Gazette deed
Registered office moved from Trooz to Visé The registered office moved from RUE GRIHANSTER, 22-4870 TROOZ to rue de Maastricht 5, 4600 Visé · resigns as director · General meeting of 17-05-2022 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
MAES PHARMCONSULT Visé €471,871 €21,025 34.1% -
JVCONSULT Bruges €482,922 €20,538 88.3% -
PROJECT STUDY AND COORDINATION SERVICES Aalst €435,366 €20,692 97.0% -
MARAF Stabroek €483,976 €20,805 81.0% 0
DE PAUW Management Consulting & Training Zottegem €440,449 €19,676 41.8% -
P.P.B. Kasterlee €426,521 €19,267 64.0% -
GMM Ranst €432,928 €23,333 91.2% -

These companies have the same main activity as MAES PHARMCONSULT: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €427,000 and €484,000, founded between 2005 and 2007.

Official details

Source: KBO
Status
Active since 24-08-2005Normal situation
Activity
Business and other management consultancyNACE 70200
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

≈ €95,000estimated
€471,871▲ 22.5%
≈ 0 FTEestimated
Filing
Filed on 07-07-2026, 24 days before the end of the filing period
Financials

Insights on MAES PHARMCONSULT

MAES PHARMCONSULT files the micro format. That format states no turnover. The gross margin fell from €30,735 in 2006 to €21,025 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MAES PHARMCONSULT

What is the company number of MAES PHARMCONSULT?
The company number of MAES PHARMCONSULT is 0875.845.464. The VAT number is the same number with BE in front: BE 0875.845.464.
Where is MAES PHARMCONSULT based?
The registered office is at Rue de Dalhem 5, 4600 Visé.Company details
What does MAES PHARMCONSULT do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of MAES PHARMCONSULT?
MAES PHARMCONSULT is a private limited company (BV).
When was MAES PHARMCONSULT founded?
MAES PHARMCONSULT was founded on 24-08-2005.
Is MAES PHARMCONSULT still active?
Yes, MAES PHARMCONSULT is an active enterprise in the KBO register.
What is the turnover of MAES PHARMCONSULT?
The turnover in financial year 2025 is about €95,000. This figure is estimated from the gross margin of €21,025 and 257 comparable companies (NACE 70200). It probably lies between €42,000 and €190,000. It is a rough estimate. In financial year 2020 turnover was €181,161.Financials
Is MAES PHARMCONSULT profitable?
In financial year 2025, MAES PHARMCONSULT made a profit of €3,689.
Where can I find the annual accounts of MAES PHARMCONSULT?
MAES PHARMCONSULT filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MAES PHARMCONSULT due?
MAES PHARMCONSULT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.